C-MET, a receptor tyrosine kinase which can bind with hepatocyte growth factor has been shown to have abnormalities in almost 50% of HCC cases (80) [65] and is involved in HCC progression [66]. The gene discussed is MET; the disease is hepatocellular carcinoma.